Association of Vitamin D receptor gene polymorphisms and clinical/severe outcomes of COVID-19 patients

التفاصيل البيبلوغرافية
العنوان: Association of Vitamin D receptor gene polymorphisms and clinical/severe outcomes of COVID-19 patients
المؤلفون: Roozbeh Heidarzadehpilehrood, Mohammad Hossein Shushizadeh, Maryam Pirhoushiaran, Razieh Zarifian Yeganeh, Ahmed Al-Kateb, Sepideh Choopani, Mina Barazandehrokh, Asaad Azarnezhad, S. Zahra Makani, Rasoul Abdollahzadeh, Sahereh Paknahad
المصدر: Infection, Genetics and Evolution
بيانات النشر: Elsevier BV, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Adult, Male, Microbiology (medical), medicine.medical_specialty, TaqI, Comorbidity, Iran, Biology, Polymorphism, Single Nucleotide, Severity of Illness Index, Microbiology, Asymptomatic, Gastroenterology, Calcitriol receptor, chemistry.chemical_compound, Clinical outcomes, Internal medicine, Genetic model, Diabetes Mellitus, Genetics, medicine, Vitamin D and neurology, Humans, Genetic Predisposition to Disease, Renal Insufficiency, Chronic, Molecular Biology, Ecology, Evolution, Behavior and Systematics, Aged, Asthma, Genetic predisposition, Single nucleotide polymorphisms (SNPs), COVID-19, Odds ratio, Middle Aged, medicine.disease, FokI, Infectious Diseases, Genes, chemistry, Vitamin D receptor, Hypertension, biology.protein, Receptors, Calcitriol, Female, medicine.symptom, Polymorphism, Restriction Fragment Length, Research Paper
الوصف: Introduction Growing evidence documented the critical impacts of vitamin D (VD) in the prognosis of COVID-19 patients. The functions of VD are dependent on the vitamin D receptor (VDR) in the VD/VDR signaling pathway. Therefore, we aimed to assess the association of VDR gene polymorphisms with COVID-19 outcomes. Methods In the present study, eight VDR single nucleotide polymorphisms (SNPs) were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 500 COVID-19 patients in Iran, including 160 asymptomatic, 250 mild/moderate, and 90 severe/critical cases. The association of these polymorphisms with severity, clinical outcomes, and comorbidities were evaluated through the calculation of the Odds ratio (OR). Results Interestingly, significant associations were disclosed for some of the SNP-related alleles and/or genotypes in one or more genetic models with different clinical data in COVID-19 patients. Significant association of VDR-SNPs with signs, symptoms, and comorbidities was as follows: ApaI with shortness of breath (P ˂ 0.001) and asthma (P = 0.034) in severe/critical patients (group III); BsmI with chronic renal disease (P = 0.010) in mild/moderate patients (group II); Tru9I with vomiting (P = 0.031), shortness of breath (P = 0.04), and hypertension (P = 0.030); FokI with fever and hypertension (P = 0.027) in severe/critical patients (group III); CDX2 with shortness of breath (P = 0.022), hypertension (P = 0.036), and diabetes (P = 0.042) in severe/critical patients (group III); EcoRV with diabetes (P ˂ 0.001 and P = 0.045 in mild/moderate patients (group II) and severe/critical patients (group III), respectively). However, the association of VDR TaqI and BglI polymorphisms with clinical symptoms and comorbidities in COVID-19 patients was not significant. Conclusion VDR gene polymorphisms might play critical roles in the vulnerability to infection and severity of COVID-19, probably by altering the risk of comorbidities. However, these results require further validation in larger studies with different ethnicities and geographical regions.
تدمد: 1567-1348
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33c392ee17e04cf59406f55d1f0c6047
https://doi.org/10.1016/j.meegid.2021.105098
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....33c392ee17e04cf59406f55d1f0c6047
قاعدة البيانات: OpenAIRE